SCHEMBL4842859

SCHEMBL4842859

COc1ccc2c(c1)C(=CC(=O)c1ccc(NC(=O)c3ccccc3F)cc1)NC(C)(C)C2

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 6/20 0.47
RAB9A P51151 4/20 0.47
TDP1 Q9NUW8 2/20 0.45
POLB P06746 2/20 0.45
KDM4E B2RXH2 2/20 0.45
NPSR1 Q6W5P4 1/20 0.45
MAPT P10636 6/20 0.44
THRB P10828 1/20 0.44
ALDH1A1 P00352 3/20 0.41
L3MBTL1 Q9Y468 1/20 0.41
MEN1 O00255 2/20 0.41
KMT2A Q03164 2/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
HPGD P15428 2/20 0.41
HTT P42858 3/20 0.40
TP53 P04637 1/20 0.40
NFKB1 P19838 1/20 0.40
NFKB2 Q00653 1/20 0.40
RELA Q04206 1/20 0.40
LMNA P02545 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4842846 1.00 NPC1 (0.47) NPC1RAB9ATDP1POLBKDM4E
SCHEMBL4844965 0.93 NPC1 (0.41) NPC1RAB9ATDP1POLBKDM4E
SCHEMBL4844957 0.93 NPC1 (0.41) NPC1RAB9ATDP1POLBKDM4E
SCHEMBL4838656 0.92 NPC1 (0.52) NPC1RAB9ATDP1POLBKDM4E
SCHEMBL4838640 0.92 NPC1 (0.52) NPC1RAB9ATDP1POLBKDM4E
SCHEMBL4841272 0.91 SNCA (0.40) NPC1RAB9AMAPTALDH1A1L3MBTL1
SCHEMBL4841259 0.91 SNCA (0.40) NPC1RAB9AMAPTALDH1A1L3MBTL1
SCHEMBL4844423 0.91 RAB9A (0.47) NPC1RAB9APOLBKDM4EMAPT
SCHEMBL4844433 0.91 RAB9A (0.47) NPC1RAB9APOLBKDM4EMAPT
SCHEMBL4835129 0.91 KMT2A (0.46) NPC1RAB9APOLBKDM4EMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7378428-B2 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2008-05-27 US disclosed
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient ONO PHARMACEUTICAL CO., LTD. (JP) 2005-10-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050222138-A1 Nitrogen-containing bicyclic compounds and drugs containing the same as the active ingredient PARK7, MMP8, CDK7 NPC1 985/4885RAB9A 2220/4885TDP1 2161/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.